Prime Medicine, Inc. - PRME

Sector: Healthcare · Industry: Biological Products, (No Diagnostic Substances)

Website: No information yet · Social: No information yet

Company profile

Latest / Compare

Q1 2026 · Q4 2025

Value (USD)

Total reported value ($000)

$378.6M

QoQ value delta ($000)

+$53.1M (+16.31%)

Implied price effect (QoQ)

+0.17%

Total shares

108,963,588

QoQ shares delta

+15,128,431 (+16.12%)

Total shares held by funds (by quarter)

Interactive chart by TradingView.

Top 25 only Full list

Partial Q1 2026 data: 194 holders have filed so far. Prior holders are carried forward until their next 13F confirms a change.

Manager	Value ($000)	Shares	% of 13F
Alphabet Inc.	57,637	16,562,498	1.44%
BlackRock, Inc.	29,585	8,501,708	0.0%
VANGUARD GROUP INC	22,443	6,467,872	0.0%
STATE STREET CORP	22,081	6,345,125	0.0%
ARK Investment Management LLC	21,738	6,246,827	0.17%
T. Rowe Price Investment Management, Inc.	19,077	5,481,893	0.01%
VANGUARD CAPITAL MANAGEMENT LLC	15,570	4,474,162	0.0%
BALYASNY ASSET MANAGEMENT L.P.	14,349	4,123,365	0.02%
Casdin Capital, LLC	11,021	3,167,175	0.83%
Woodline Partners LP	10,451	3,003,313	0.04%
Sumitomo Mitsui Trust Group, Inc.	10,233	2,940,793	0.01%
Amova Asset Management Americas, Inc.	10,204	2,940,793	0.14%
UBS Group AG	10,051	2,888,418	0.0%
GEODE CAPITAL MANAGEMENT, LLC	9,550	2,743,700	0.0%
ADAR1 Capital Management, LLC	6,867	1,973,282	0.4%
MWG Caph Ltd	6,218	1,792,210	8.59%
FMR LLC	6,157	1,769,476	0.0%
Redmile Group, LLC	5,536	1,590,832	0.37%
TWO SIGMA INVESTMENTS, LP	5,473	1,572,811	0.0%
D. E. Shaw & Co., Inc.	4,849	1,393,621	0.0%
SUSQUEHANNA INTERNATIONAL GROUP, LLP	4,697	1,349,829	0.0%
FARALLON CAPITAL MANAGEMENT LLC	4,318	1,240,843	0.02%
GOLDMAN SACHS GROUP INC	3,377	970,425	0.0%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	3,191	917,212	0.0%
NORTHERN TRUST CORP	3,085	886,716	0.0%